ISSUES IN THE MORTALITY ANALYSIS OF RANDOMIZED CONTROLLED TRIALS OF CANCER SCREENING

被引:22
作者
CONNOR, RJ
ENG, D
PROROK, PC
机构
[1] Biometry Branch, Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD
来源
CONTROLLED CLINICAL TRIALS | 1994年 / 15卷 / 02期
关键词
D O I
10.1016/0197-2456(94)90014-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This paper is concerned with the analysis and interpretation of randomized controlled trials (RCTs) of periodic screening programs for the early detection of cancer in which there is a lengthy follow-up period without screening being offered. That is, screening is offered for a limited time with a subsequent follow-up period during which the cancer mortality is observed. The paper focuses on tests for a mortality reduction due to screening. Two approaches are presented, one based on the experience of all those randomized to the test and control groups, and the other based on the experience of selected groups of cancer cases found during the trial. In the latter approach it is necessary that the two groups selected for analysis be comparable groups of cancers. The concept of comparability is discussed with emphasis on factors that determine comparability and on ways to assess it. Examples from completed cancer screening RCTs are used to illustrate the ideas and methods presented.
引用
收藏
页码:81 / 99
页数:19
相关论文
共 16 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS
[2]   AN ANALYSIS OF THE MORTALITY EFFECT IN A BREAST-CANCER SCREENING STUDY [J].
ARON, JL ;
PROROK, PC .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1986, 15 (01) :36-43
[3]   FINAL REPORTS OF NATIONAL-CANCER-INSTITUTE AD HOC WORKING GROUPS ON MAMMOGRAPHY IN SCREENING FOR BREAST-CANCER AND A SUMMARY REPORT OF THEIR JOINT FINDINGS AND RECOMMENDATIONS [J].
BRESLOW, L ;
THOMAS, LB ;
UPTON, AC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 59 (02) :467-541
[4]   ANALYSIS OF BREAST-CANCER MORTALITY AND STAGE DISTRIBUTION BY AGE FOR THE HEALTH-INSURANCE PLAN CLINICAL-TRIAL [J].
CHU, KC ;
SMART, CR ;
TARONE, RE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (14) :1125-1132
[5]  
COX DR, 1966, STATISTICAL ANAL SER
[6]  
FONTANA RS, 1986, LUNG CANCER BASIC CL, P91
[7]  
GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[8]  
HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317
[9]  
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
[10]  
Morrison A, 1985, SCREENING CHRONIC DI